SensArs

Curated by Signal

A hybrid neuroprosthetic device

Overview

SensArs Neuroprosthetics is developing SENSY, a hybrid neuroprosthetic device comprising the intraneural electrode for sensory nerve stimulation. It will be implanted within the residual nerves, or healthy part of the nerves, restoring the natural-like flow of the neural sensory information. It will enable subjects to feel natural and complete sensations from the missing or non-functional limb.

Key facts

Founded: 2014
Headquarters: Saint Sulpice, Switzerland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

AirCurve Medical
Developer of a medical device for the treatment of pulmonology disorders
Life Sciences TechnologyLausanne, Switzerland
Gondola Medical Technologies
Developer of a medical device for neurodegenerative disorders
Life Sciences TechnologyEpalinges, Switzerland
Medirio
Developer of a medical device for Insulin delivery
Life Sciences TechnologySierre, Switzerland

About SensArs

What does SensArs do?

SensArs Neuroprosthetics is developing SENSY, a hybrid neuroprosthetic device comprising the intraneural electrode for sensory nerve stimulation.

Where is SensArs headquartered?

SensArs is headquartered in Saint Sulpice, Switzerland.

When was SensArs founded?

SensArs was founded in 2014.

Which sector is SensArs in?

SensArs operates in Life Sciences Technology.

Who are SensArs's competitors?

Companies similar to SensArs include AirCurve Medical, Gondola Medical Technologies, and Medirio.